Stem Cell Laboratory

Θερμές ευχαριστίες για το Βραβείο Εξαίρετης Δημοσίευσης «Παναγιώτης Κανελλόπουλος» του Πανεπιστημίου Πατρών για το έτος 2024

Lara-Castor, L., O’Hearn, M., Cudhea, F. et al. Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries. Nat Med (2025).

Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries - Nature Medicine Estimates from the Global Dietary Database indicated that 2.2 million new type 2 diabetes and 1.2 million new cardiovascular disease cases were attributable to sugar-sweetened beverages worldwide in 2020, with the highest burdens in sub-Saharan Africa, Latin America and the Caribbean.

New therapies are coming closer

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be here More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy.

A new study by a Greek research group gives hope for the treatment of hydrocephalus - Hellenic Society of Gene Therapy and Regenerative Medicine   The Laboratory of Physiology of the Department of Medicine of the University of Patras led by Professor Stavros Taraviras has published a new paper in the journal EMBO Molecular…

We are very proud for the post dedicated to our work by the Hydrocephalus Association for Discovery Science. Our dream is our finding to offer cure for hydrocephalus patients in the future.

Regenerating Ependymal Cells as a Potential Therapeutic Strategy for Hydrocephalus – Hydrocephalus Association Network for Discovery Science Hydrocephalus, a prevalent neurological condition, is characterized by the abnormal accumulation of cerebrospinal fluid (CSF) within the brain ventricles. Current therapeutic approaches partially alleviate symptoms but fail to address the underlying pathology and frequently lead to complications. Lo...

We are thrilled as our work has been published to the prestigious journal EMBO Molecular Medicine.

Ependymal cell lineage reprogramming as a potential therapeutic intervention for hydrocephalus | EMBO Molecular Medicine imageimageMcIdas and GemC1 convert different cell types into ependymal cells both ex vivo and in vivo in hydrocephalic animal models, thus suggesting a new therapeutic intervention aiming at the regeneration of damaged ependymal cells in human ...

World-first stem-cell treatment restores vision in people The treatment, given to four people with damaged corneas, seems safe but needs to be tested in larger trials.

Είναι μεγάλη μου τιμή και χαρά να συμμετέχω με την εναρκτήρια διάλεξη στο 24ο Μετεκπαιδευτικό συνέδριο με τίτλο "Εξελίξεις στην Ογκολογία", 8-9 Νοεμβρίου 2024 στο Συνεδριακό και Πολιτιστικό Κέντρο του Πανεπιστημιου Πατρών. Ευχαριστώ τον Καθηγητή Χ. Καλοφωνο για την τιμητική πρόσκληση.

GENEDIS 2024

Medicine Nobel awarded for gene-regulating ‘microRNAs' Victor Ambros and Gary Ruvkun identified a class of tiny molecules that have a crucial role in controlling gene expression.

Πρόγραμμα Μεταπτυχιακών Σπουδών στις Βιοιατρικές Επιστήμες, Τμήμα Ιατρικής, Πανεπιστήμιο Πατρών.
Φοίτηση δωρεάν.

The benefits of GLP-1 drugs beyond obesity Glucagon-like peptide–1–based medicines have weight loss–independent actions